Delek Air Tree
Delek Air Tree (Memecylon edule, family Melastomataceae) is a tropical evergreen whose leaves are rich in quercetin, gallic acid, ellagic acid, kaempferol, myricetin, tannins, and triterpenoids—polyphenolic compounds that exhibit potent free-radical scavenging and NF-κB–mediated anti-inflammatory activity in cell-free and in-vitro assays. As of mid-2025, no indexed randomized controlled trials in human subjects exist; all reported bioactivities derive from phytochemical screening and in-vitro studies published in regional pharmacognosy journals, so efficacy claims remain preclinical.
Origin & History
Delek Air Tree (Dalbergia parviflora) is a tropical tree native to the humid lowland forests of Southeast Asia, particularly Malaysia, Indonesia, and Thailand. Its bark and leaves are rich in bioactive compounds, making it a valuable botanical. It is recognized in functional nutrition for its traditional use in supporting respiratory, immune, and circulatory health.
Historical & Cultural Context
The Delek Air Tree has been traditionally used in Malay and Indigenous medicine to strengthen the lungs, purify the blood, and restore overall vitality. Its applications spanned respiratory and liver health, reflecting its deep integration into Southeast Asian traditional healing systems.
Health Benefits
- **Supports lung health**: by acting as a respiratory tonic and expectorant. - **Reduces inflammation throughout**: the body due to its anti-inflammatory compounds. - **Enhances immunity by**: modulating immune responses and providing antimicrobial effects. - **Improves circulation, supporting**: cardiovascular health and blood flow. - **Promotes liver detoxification,**: aiding the body's natural cleansing processes. - **Nourishes skin, contributing**: to its health and vitality.
How It Works
The proposed bioactivity of Memecylon edule leaves centers on flavonoids—principally quercetin, kaempferol, and myricetin—which in cell-free and cell-based in-vitro models inhibit nuclear factor kappa-B (NF-κB) signaling by preventing IκBα phosphorylation and subsequent proteasomal degradation, thereby reducing transcription of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Gallic acid and ellagic acid contribute additional redox-modulating capacity by donating phenolic hydrogen atoms to neutralize superoxide (O₂⁻), hydroxyl (·OH), and peroxyl (ROO·) radicals, as demonstrated in DPPH and ABTS radical-scavenging assays. Condensed tannins (proanthocyanidins) in the leaf matrix may inhibit cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) enzyme activity, potentially reducing prostaglandin E₂ and leukotriene B₄ synthesis, while triterpenoids such as ursolic acid have been shown in analogous plant systems to modulate Nrf2-Keap1 antioxidant-response-element signaling, upregulating phase II detoxification enzymes including glutathione S-transferase and heme oxygenase-1. These mechanisms remain demonstrated only in vitro and in silico; no human pharmacokinetic or pharmacodynamic data have been published for Memecylon edule leaf preparations.
Scientific Research
As of mid-2025, systematic searches across PubMed, Scopus, Web of Science, and EMBASE return zero indexed randomized controlled trials or formal clinical studies conducted specifically on Memecylon edule leaf extracts in human subjects. The existing peer-reviewed literature is confined to phytochemical screening papers and in-vitro bioactivity assays published in regional journals such as the Journal of Pharmacognosy and Phytochemistry, the International Journal of Pharmaceutical Sciences and Research, and the Asian Journal of Pharmaceutical and Clinical Research. These studies have characterized the leaf's polyphenol profile—identifying quercetin, gallic acid, ellagic acid, kaempferol, myricetin, and condensed tannins—and reported antioxidant activity via DPPH, ABTS, and FRAP assays as well as antibacterial effects against Staphylococcus aureus and Escherichia coli in disc-diffusion models. No PMID-indexed clinical or animal pharmacokinetic data are currently available, meaning all health-benefit claims remain at the preclinical stage and require rigorous human validation.
Clinical Summary
Current evidence for Delek Air Tree is limited to preclinical in vitro studies using THP-1 monocytic cell lines. Ethyl acetate leaf extracts showed significant anti-proliferative activity and cytotoxicity, though specific IC50 values were not quantified in available research. No clinical trials in human subjects have been conducted, making this ingredient's therapeutic applications purely theoretical based on laboratory cell culture studies. The evidence strength is weak and requires substantial clinical validation.
Nutritional Profile
- Minerals: Potassium, Magnesium, Zinc - Phytochemicals: Polyphenols, Flavonoids (catechins, ellagic acid), Tannins, Saponins, Plant sterols, Bitter alkaloids
Preparation & Dosage
- Traditionally used in decoctions and infusions for respiratory and liver health. - Applied topically for skin healing in traditional practices. - Modern uses include lung-support supplements, detox blends, and cardiovascular formulations. - Recommended dosage: 500–1000 mg of powdered bark or leaf extract daily.
Synergy & Pairings
Role: Polyphenol/antioxidant base Intention: Detox & Liver | Cardio & Circulation Primary Pairings: - Licorice Root (Glycyrrhiza glabra) - Turmeric (Curcuma longa) - Milk Thistle (Silybum marianum) - Ginkgo Biloba (Ginkgo biloba)
Safety & Interactions
No formal toxicological studies, maximum-tolerated-dose assays, or adverse-event reports for Memecylon edule leaf extracts have been published in indexed literature as of mid-2025, so a definitive safety profile cannot be established. Given the high tannin content of the leaves, oral consumption may reduce the bioavailability of iron and other divalent minerals and could theoretically potentiate the effects of anticoagulant and antiplatelet drugs (e.g., warfarin, aspirin) due to the known platelet-modulatory properties of quercetin and kaempferol. Quercetin is a documented inhibitor of CYP3A4, CYP2C9, and CYP1A2 in vitro, raising the possibility of herb-drug interactions with substrates of these enzymes (e.g., statins, NSAIDs, certain SSRIs) if the flavonoids are absorbed at pharmacologically relevant concentrations. Pregnant or breastfeeding individuals, children, and persons on prescription medications should consult a qualified healthcare provider before using Delek Air Tree leaf preparations.